Zeglu-GP2 Tablets – Glimepiride 2mg Metformin 500mg Pioglitazone 15mg Tablets Manufacturer, Supplier, Franchise In India
Zeglu-GP2 Tablets are a potent triple-combination oral antidiabetic medication formulated for the effective management of type 2 diabetes mellitus. Each tablet contains Glimepiride 2 mg, Metformin 500 mg, and Pioglitazone 15 mg, working synergistically to control blood sugar levels and improve overall glycemic management.
Mechanism of Action
Zeglu-GP2 Tablets employ a triple mechanism for effective glycemic control:
Insulin Secretion – Glimepiride promotes insulin release in response to high blood sugar levels.
Insulin Sensitivity – Metformin and Pioglitazone enhance the body’s response to insulin, reducing blood sugar efficiently.
Hepatic Glucose Control – Metformin decreases glucose production by the liver, preventing hyperglycemia
Key Benefits of Glimepiride 2mg Metformin 500mg Pioglitazone 15mg Tablets
Provides comprehensive blood sugar management for fasting and post-prandial levels, Addresses insulin resistance and insufficient insulin production simultaneously, Reduces the risk of long-term diabetes complications, Sustains glucose control throughout the day with minimal risk of hypoglycemia & Convenient single-tablet regimen for better adherence.
Manufacturer of Zeglu-GP2 Tablets in India
Zeglu-GP2 Tablets are manufactured in compliance with stringent GMP (Good Manufacturing Practices) and quality standards to ensure safety, efficacy, and consistency. The manufacturing units adhere to the latest pharmaceutical regulations, providing high-quality antidiabetic medication for both domestic and international markets.
Franchise Opportunities
We offer lucrative franchise and PCD (Propaganda-Cum-Distribution) opportunities for Zeglu-GP2 Tablets across India. Partnering with us provides:
-
Monopoly rights in designated regions
-
Marketing and promotional support
-
High-quality packaging and branded materials
-
Access to a range of other pharmaceutical products for portfolio expansion
Becoming a franchise partner with us enables healthcare professionals and entrepreneurs to participate in the growing diabetes care market in India while offering reliable and effective antidiabetic solutions to patients.
